Selumetinib-[d4]

General Information
Catalog: BLP-004220
Molecular Formula: C17H11D4BrClFN4O3
Molecular Weight: 461.71
Description Isotopic labelled Selumetinib, also known as AZD6244, is an orally bioavailable small molecule with potential antineoplastic activity. Selumetinib inhibits mitogen-activated protein kinase kinases (MEK or MAPK/ERK kinases) 1 and 2, which may prevent the activation of MEK1/2-dependent effector proteins and transcription factors, and so may inhibit cellular proliferation in MEK-overexpressing tumor cells. MEK 1 and 2 are dual-specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various tumor cell types, and are drivers of diverse cellular activities, including cellular proliferation. Check for active clinical trials or closed clinical trials using this agent.
Related CAS 606143-52-6 (unlabelled)
Purity >98%

Related Products

Online Inquiry


  • Verification code

USA

UK

Share

Interested in our Service & Products?
Need detailed information?



Inquiry Basket